Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the …
BM Demaerschalk, DO Kleindorfer, OM Adeoye… - Stroke, 2016 - Am Heart Assoc
Purpose—To critically review and evaluate the science behind individual eligibility criteria
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …
Hemorrhagic stroke
A Montaño, DF Hanley, JC Hemphill III - Handbook of clinical neurology, 2021 - Elsevier
Hemorrhagic stroke comprises about 20% of all strokes, with intracerebral hemorrhage
(ICH) being the most common type. Frequency of ICH is increased where hypertension is …
(ICH) being the most common type. Frequency of ICH is increased where hypertension is …
Factors influencing haemorrhagic transformation in ischaemic stroke
J Álvarez-Sabín, O Maisterra, E Santamarina… - The Lancet …, 2013 - thelancet.com
Haemorrhagic transformation (HT) of ischaemic infarction occurs when an area of brain
infarction is stained with blood products, mainly red blood cells. An abnormally permeable …
infarction is stained with blood products, mainly red blood cells. An abnormally permeable …
Absolute and relative contraindications to IV rt-PA for acute ischemic stroke
JE Fugate, AA Rabinstein - The Neurohospitalist, 2015 - journals.sagepub.com
Most of the contraindications to the administration of intravenous (IV) recombinant tissue
plasminogen activator (rtPA) originated as exclusion criteria in major stroke trials. These …
plasminogen activator (rtPA) originated as exclusion criteria in major stroke trials. These …
Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator
Background and Purpose—There are few validated models for prediction of risk of
symptomatic intracranial hemorrhage (sICH) after intravenous tissue-type plasminogen …
symptomatic intracranial hemorrhage (sICH) after intravenous tissue-type plasminogen …
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and …
Dabigatran, apixaban, and rivaroxaban have been approved for primary and secondary
stroke prevention in patients with atrial fibrillation. However, questions have arisen about …
stroke prevention in patients with atrial fibrillation. However, questions have arisen about …
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator
Context Intravenous tissue plasminogen activator (tPA) is known to improve outcomes in
ischemic stroke; however, patients receiving long-term chronic warfarin therapy may face an …
ischemic stroke; however, patients receiving long-term chronic warfarin therapy may face an …
Society for Neuroscience in Anesthesiology and Critical Care Expert consensus statement: anesthetic management of endovascular treatment for acute ischemic …
Literature on the anesthetic management of endovascular treatment of acute ischemic stroke
(AIS) is limited. Anesthetic management during these procedures is still mostly dependent …
(AIS) is limited. Anesthetic management during these procedures is still mostly dependent …
Thrombolysis in stroke despite contraindications or warnings?
Background and Purpose—Intravenous thrombolysis with alteplase is approved for acute
ischemic stroke, but its use is limited by numerous contraindications and warnings arising …
ischemic stroke, but its use is limited by numerous contraindications and warnings arising …
Republished: Society for Neuroscience in Anesthesiology and Critical Care expert consensus statement: Anesthetic management of endovascular treatment for acute …
Literature on the anesthetic management of endovascular treatment of acute ischemic stroke
(AIS) is limited. Anesthetic management during these procedures is still mostly dependent …
(AIS) is limited. Anesthetic management during these procedures is still mostly dependent …